• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆来源的外泌体群体在头颈癌中的免疫抑制作用

Immune Suppressive Effects of Plasma-Derived Exosome Populations in Head and Neck Cancer.

作者信息

Beccard Inga J, Hofmann Linda, Schroeder Jan C, Ludwig Sonja, Laban Simon, Brunner Cornelia, Lotfi Ramin, Hoffmann Thomas K, Jackson Edwin K, Schuler Patrick J, Theodoraki Marie-Nicole

机构信息

Department of Otorhinolaryngology, Head and Neck Surgery, University of Ulm, 89070 Ulm, Germany.

Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Mannheim, 68167 Mannheim, Germany.

出版信息

Cancers (Basel). 2020 Jul 21;12(7):1997. doi: 10.3390/cancers12071997.

DOI:10.3390/cancers12071997
PMID:32708274
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7409343/
Abstract

Plasma-derived exosomes of head and neck squamous cell carcinoma (HNSCC) patients carry inhibitory factors mediating immune suppression. Separation of tumor-derived exosomes (TEX) and non-TEX may assist in a better understanding of their respective parental cells. Here, we evaluate the impact of TEX or hematopoietic-derived exosomes on immune suppression. We evaluated apoptosis in CD8+ T cells, conversion of CD4+ T cells to regulatory T cells (T), and adenosine production by TEX, non-TEX, or total exosomes. Exosome protein cargo was significantly higher in total and CD45(-) exosomes from high stage compared to low stage patients. Furthermore, total and CD45(-) exosomes of high stage patients induced more apoptosis in CD8+ T cells than their low stage counterparts. CD69 suppression, a marker of reduced CD8+ T cell activation, was only mediated by CD45(-) exosomes. All fractions induced T differentiation, defined by CD39 expression, but only CD45(-) exosomes showed a stage-dependent conversion. CD45(-) exosomes produced higher adenosine concentrations than CD45(+) exosomes, concluding that adenosine production measured in total exosomes mainly derives from TEX. The presented results show significant induction of immune suppression by TEX in HNSCC. This immunosuppressive effect supports the potential role of exosomes as liquid biomarkers for disease stage and level of immune suppression.

摘要

头颈部鳞状细胞癌(HNSCC)患者的血浆来源外泌体携带介导免疫抑制的抑制因子。分离肿瘤来源的外泌体(TEX)和非TEX可能有助于更好地了解它们各自的亲代细胞。在此,我们评估TEX或造血来源的外泌体对免疫抑制的影响。我们评估了CD8+T细胞中的细胞凋亡、CD4+T细胞向调节性T细胞(T)的转化以及TEX、非TEX或总外泌体产生的腺苷。与低分期患者相比,高分期患者的总外泌体和CD45(-)外泌体中的外泌体蛋白含量显著更高。此外,高分期患者的总外泌体和CD45(-)外泌体比低分期患者的外泌体在CD8+T细胞中诱导更多的细胞凋亡。CD69抑制是CD8+T细胞活化降低的标志物,仅由CD45(-)外泌体介导。所有组分均诱导由CD39表达定义的T细胞分化,但只有CD45(-)外泌体显示出阶段依赖性转化。CD45(-)外泌体产生的腺苷浓度高于CD45(+)外泌体,得出总外泌体中测量的腺苷产生主要来自TEX的结论。所呈现的结果表明HNSCC中TEX对免疫抑制有显著诱导作用。这种免疫抑制作用支持外泌体作为疾病阶段和免疫抑制水平的液体生物标志物的潜在作用。

相似文献

1
Immune Suppressive Effects of Plasma-Derived Exosome Populations in Head and Neck Cancer.血浆来源的外泌体群体在头颈癌中的免疫抑制作用
Cancers (Basel). 2020 Jul 21;12(7):1997. doi: 10.3390/cancers12071997.
2
Separation of plasma-derived exosomes into CD3 and CD3 fractions allows for association of immune cell and tumour cell markers with disease activity in HNSCC patients.将血浆衍生的外泌体分离成 CD3 和 CD3 两个部分,可使免疫细胞和肿瘤细胞标志物与 HNSCC 患者的疾病活动相关联。
Clin Exp Immunol. 2018 Jun;192(3):271-283. doi: 10.1111/cei.13113. Epub 2018 Mar 12.
3
Cargo and Functional Profile of Saliva-Derived Exosomes Reveal Biomarkers Specific for Head and Neck Cancer.唾液来源外泌体的货物和功能谱揭示了头颈癌特异性生物标志物。
Front Med (Lausanne). 2022 Jul 11;9:904295. doi: 10.3389/fmed.2022.904295. eCollection 2022.
4
Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets.肿瘤来源的外泌体调节人类T细胞亚群中免疫功能相关基因的表达。
Sci Rep. 2016 Feb 4;6:20254. doi: 10.1038/srep20254.
5
CD44v3 protein-carrying tumor-derived exosomes in HNSCC patients' plasma as potential noninvasive biomarkers of disease activity.头颈部鳞状细胞癌患者血浆中携带CD44v3蛋白的肿瘤衍生外泌体作为疾病活动的潜在无创生物标志物。
Oncoimmunology. 2020 Apr 7;9(1):1747732. doi: 10.1080/2162402X.2020.1747732. eCollection 2020.
6
Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRT.循环外泌体可衡量接受西妥昔单抗、伊匹单抗和调强放疗的头颈癌患者对治疗的反应。
Oncoimmunology. 2019 Apr 24;8(7):1593805. doi: 10.1080/2162402X.2019.1593805. eCollection 2019.
7
Exosomes in HNSCC plasma as surrogate markers of tumour progression and immune competence.头颈部鳞状细胞癌血浆中的外泌体作为肿瘤进展和免疫能力的替代标志物。
Clin Exp Immunol. 2018 Oct;194(1):67-78. doi: 10.1111/cei.13157. Epub 2018 Sep 19.
8
Human tumor-derived exosomes (TEX) regulate Treg functions via cell surface signaling rather than uptake mechanisms.人肿瘤来源的外泌体(TEX)通过细胞表面信号传导而非摄取机制调节调节性T细胞(Treg)的功能。
Oncoimmunology. 2017 Jul 19;6(8):e1261243. doi: 10.1080/2162402X.2016.1261243. eCollection 2017.
9
The Potential of CD16 on Plasma-Derived Exosomes as a Liquid Biomarker in Head and Neck Cancer.血浆衍生外泌体 CD16 作为头颈部癌症液体生物标志物的潜力。
Int J Mol Sci. 2020 May 26;21(11):3739. doi: 10.3390/ijms21113739.
10
Differential Immunomodulatory Effects of Head and Neck Cancer-Derived Exosomes on B Cells in the Presence of ATP.头颈部癌来源外泌体在 ATP 存在下对 B 细胞的差异免疫调节作用。
Int J Mol Sci. 2022 Nov 21;23(22):14446. doi: 10.3390/ijms232214446.

引用本文的文献

1
The role of plasma-derived small extracellular vesicles in pre-metastatic niche formation through modulation of macrophages in head and neck squamous cell carcinoma.血浆来源的小细胞外囊泡通过调节巨噬细胞在头颈部鳞状细胞癌前转移微环境形成中的作用。
Br J Cancer. 2025 May 5. doi: 10.1038/s41416-025-03001-9.
2
Application of exosomes in tumor immunity: recent progresses.外泌体在肿瘤免疫中的应用:最新进展
Front Cell Dev Biol. 2024 Apr 3;12:1372847. doi: 10.3389/fcell.2024.1372847. eCollection 2024.
3
Optimization of extracellular vesicles preparation from saliva of head and neck cancer patients.

本文引用的文献

1
CD44v3 protein-carrying tumor-derived exosomes in HNSCC patients' plasma as potential noninvasive biomarkers of disease activity.头颈部鳞状细胞癌患者血浆中携带CD44v3蛋白的肿瘤衍生外泌体作为疾病活动的潜在无创生物标志物。
Oncoimmunology. 2020 Apr 7;9(1):1747732. doi: 10.1080/2162402X.2020.1747732. eCollection 2020.
2
Melanoma cell-derived exosomes in plasma of melanoma patients suppress functions of immune effector cells.黑色素瘤患者血浆中的黑色素瘤细胞衍生的外泌体抑制免疫效应细胞的功能。
Sci Rep. 2020 Jan 9;10(1):92. doi: 10.1038/s41598-019-56542-4.
3
Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRT.
从头颈部癌症患者的唾液中优化细胞外囊泡的制备。
Sci Rep. 2024 Jan 10;14(1):946. doi: 10.1038/s41598-023-50610-6.
4
Circular and Circulating DNA in Inflammatory Bowel Disease: From Pathogenesis to Potential Molecular Therapies.炎症性肠病中的环状和循环DNA:从发病机制到潜在的分子疗法
Cells. 2023 Jul 27;12(15):1953. doi: 10.3390/cells12151953.
5
Plasma-derived small extracellular vesicles unleash the angiogenic potential in head and neck cancer patients.血浆衍生的小细胞外囊泡释放头颈部癌症患者的血管生成潜能。
Mol Med. 2023 May 24;29(1):69. doi: 10.1186/s10020-023-00659-w.
6
Evaluating tumor cell- and T cell-derived extracellular vesicles as potential biomarkers of cancer and immune cell competence.评估肿瘤细胞和 T 细胞衍生的细胞外囊泡作为癌症和免疫细胞功能的潜在生物标志物。
Expert Rev Mol Diagn. 2023 Feb;23(2):109-122. doi: 10.1080/14737159.2023.2178902. Epub 2023 Feb 18.
7
Tumor-Derived Extracellular Vesicles in Cancer Immunoediting and Their Potential as Oncoimmunotherapeutics.肿瘤来源的细胞外囊泡在癌症免疫编辑中的作用及其作为肿瘤免疫治疗药物的潜力
Cancers (Basel). 2022 Dec 23;15(1):82. doi: 10.3390/cancers15010082.
8
Extracellular Vesicles and Their Roles in the Tumor Immune Microenvironment.细胞外囊泡及其在肿瘤免疫微环境中的作用
J Clin Med. 2022 Nov 22;11(23):6892. doi: 10.3390/jcm11236892.
9
Differential Immunomodulatory Effects of Head and Neck Cancer-Derived Exosomes on B Cells in the Presence of ATP.头颈部癌来源外泌体在 ATP 存在下对 B 细胞的差异免疫调节作用。
Int J Mol Sci. 2022 Nov 21;23(22):14446. doi: 10.3390/ijms232214446.
10
Isolation and analysis of tumor‑derived extracellular vesicles from head and neck squamous cell carcinoma plasma by galectin‑based glycan recognition particles.基于半乳糖凝集素的糖识别颗粒从头颈鳞状细胞癌血浆中分离和分析肿瘤衍生的细胞外囊泡。
Int J Oncol. 2022 Nov;61(5). doi: 10.3892/ijo.2022.5423. Epub 2022 Sep 21.
循环外泌体可衡量接受西妥昔单抗、伊匹单抗和调强放疗的头颈癌患者对治疗的反应。
Oncoimmunology. 2019 Apr 24;8(7):1593805. doi: 10.1080/2162402X.2019.1593805. eCollection 2019.
4
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines.细胞外囊泡研究的最低限度信息2018(MISEV2018):国际细胞外囊泡协会的立场声明及MISEV2014指南的更新
J Extracell Vesicles. 2018 Nov 23;7(1):1535750. doi: 10.1080/20013078.2018.1535750. eCollection 2018.
5
The potential of tumor-derived exosomes for noninvasive cancer monitoring: an update.肿瘤来源的外泌体在非侵入性癌症监测中的潜力:最新进展。
Expert Rev Mol Diagn. 2018 Dec;18(12):1029-1040. doi: 10.1080/14737159.2018.1544494. Epub 2018 Nov 9.
6
Exosomes in HNSCC plasma as surrogate markers of tumour progression and immune competence.头颈部鳞状细胞癌血浆中的外泌体作为肿瘤进展和免疫能力的替代标志物。
Clin Exp Immunol. 2018 Oct;194(1):67-78. doi: 10.1111/cei.13157. Epub 2018 Sep 19.
7
Separation of plasma-derived exosomes into CD3 and CD3 fractions allows for association of immune cell and tumour cell markers with disease activity in HNSCC patients.将血浆衍生的外泌体分离成 CD3 和 CD3 两个部分,可使免疫细胞和肿瘤细胞标志物与 HNSCC 患者的疾病活动相关联。
Clin Exp Immunol. 2018 Jun;192(3):271-283. doi: 10.1111/cei.13113. Epub 2018 Mar 12.
8
CD45 in human physiology and clinical medicine.CD45 在人类生理学和临床医学中的应用。
Immunol Lett. 2018 Apr;196:22-32. doi: 10.1016/j.imlet.2018.01.009. Epub 2018 Jan 31.
9
Clinical Significance of PD-L1 Exosomes in Plasma of Head and Neck Cancer Patients.头颈部癌症患者血浆中 PD-L1 外泌体的临床意义。
Clin Cancer Res. 2018 Feb 15;24(4):896-905. doi: 10.1158/1078-0432.CCR-17-2664. Epub 2017 Dec 12.
10
The effect of tumor-derived exosomes on immune regulation and cancer immunotherapy.肿瘤来源的外泌体对免疫调节和癌症免疫治疗的影响。
Future Oncol. 2017 Dec;13(28):2583-2592. doi: 10.2217/fon-2017-0343. Epub 2017 Dec 4.